Rani Therapeutics nets $69M to transform injections into its easy-to-swallow ‘robotic pill’ – Fierce Biotech

Written by: Conor Hale

Rani Therapeutics has secured $69 million in new funding to move forward with the manufacturing and clinical testing of its “robotic pill”—a small, swallowable capsule that promises to shepherd more delicate drugs past the stomach before releasing them into the bloodstream.

The pill aims to make it easier for a patient to take therapies that typically require an injection or infusion, including treatments for diabetes, arthritis and other diseases.

Read more here

By Valerie Lam
Valerie Lam Profile Picture